Clinical Trial Update: Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating allogeneic stem cell transplantation for chronic myeloid leukemia patients failing TKI therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Leukemia
• Myelogenous Leukemia

Snippet

Sponsor: University of Milano Bicocca | Conditions: Leukemia, Myelogenous | Phase 2 | Status: COMPLETED